Newest first
New topics page 23
Topics ordered by when they were created rather than by activity. This is where a question that nobody has answered yet is easiest to find — and answering one is the fastest route to a first solution badge.
1,535 topics · page 23 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
EMA product information as a primary source
Posting this under the heading it deserves: EMA product information as a primary source Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…
|
+70 | 74 | 7k | 8mo |
|
Follow-up: What a seizure notice actually says
What a seizure notice actually says — that is the question, and I have not found it answered plainly anywhere I have looked. Structured report rather than an opinion, following the format the maintainers…
|
+35 | 41 | 490 | 9mo |
|
Which panel is worth repeating and which is worth ignoring — a second dataset
Asking directly, because I could not find a straight answer: Which panel is worth repeating and which is worth ignoring — a second dataset General question, not a request for advice about my own care — I know…
|
+108 | 117 | 46k | 4mo |
|
Pharmaceutical compounding rules, summarised from primary sources — a second dataset
Posting this under the heading it deserves: Pharmaceutical compounding rules, summarised from primary sources — a second dataset Everything below is what sits behind that. A logistics question, since the…
|
+50 | 56 | 780 | 8mo |
|
Oral versus injectable exposure: comparing apples to a different fruit
Oral versus injectable exposure: comparing apples to a different fruit — setting out what I have, and where I think it stops being reliable. Comparing SURMOUNT-2 ( Lancet , 2023) with SURMOUNT-4 ( JAMA ,…
|
+19 | 23 | 332 | 8mo |
|
Common supplements people ask about, assessed one at a time — a second dataset
Posting this under the heading it deserves: Common supplements people ask about, assessed one at a time — a second dataset Everything below is what sits behind that. Reporting something rather than asking…
|
+97 | 104 | 15k | 3mo |
|
Absolute versus relative contraindications
On the subject in the title: Absolute versus relative contraindications Working notes rather than a conclusion. General question, not a request for advice about my own care — I know the difference and I would…
|
+4 | 8 | 23k | 8mo |
|
A parcel stationary at a customs facility for nine days
On the subject in the title: A parcel stationary at a customs facility for nine days Working notes rather than a conclusion. A logistics question, since the answers here are usually better than anywhere else…
|
+64 | 72 | 51k | 1mo |
|
Turnaround times and what they mean for a decision
Turnaround times and what they mean for a decision Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than…
|
4 | 29k | 3mo | |
|
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on
Posting this under the heading it deserves: SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Everything below is what sits behind that. Comparing SURPASS-2 ( N Engl J Med…
|
+122 | 136 | 48k | 9mo |
|
Payment mechanics and the recovery options that do not exist
Payment mechanics and the recovery options that do not exist Writing it up because I had to work it out twice and would rather nobody else did. I would like to talk about documentation quality as a signal,…
|
+80 | 89 | 24k | 9mo |
|
Run-in periods and the population they select — the long version
Run-in periods and the population they select — the long version Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SUSTAIN 6 ( N Engl J Med , 2016). Please read…
|
2 | 8.9k | 4mo | |
|
A widely repeated interaction claim that turns out to be unsupported
On the subject in the title: A widely repeated interaction claim that turns out to be unsupported Working notes rather than a conclusion. Practical question with the units stated, because I have seen how…
|
+47 | 51 | 37k | 3mo |
|
Amylin receptor signalling and satiety
Amylin receptor signalling and satiety Writing it up because I had to work it out twice and would rather nobody else did. A documentation question rather than an analytical one. I have a certificate in front…
|
+22 | 26 | 1.8k | 9mo |
|
Why "add 2 mL" is not an instruction
The question in the title: Why "add 2 mL" is not an instruction I will give what I have already checked below so nobody repeats it. A question about technique rather than about dose. I have been doing the…
|
+23 | 27 | 3.5k | 6mo |
|
The anatomy of a question that gets answered within an hour — the long version
The anatomy of a question that gets answered within an hour — the long version Writing it up because I had to work it out twice and would rather nobody else did. Question in the title. Context below, and I…
|
+129 | 142 | 49k | 8mo |
|
Price changes over 2025 and 2026, tabulated and dated — does this still hold?
Price changes over 2025 and 2026, tabulated and dated — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated,…
|
+147 | 156 | 18k | 3mo |
|
Second pass at: I joined for one answer and stayed for a year — what changed my mind
Second pass at: I joined for one answer and stayed for a year — what changed my mind — setting out what I have, and where I think it stops being reliable. Question in the title. Context below, and I have…
|
4 | 25k | 2mo | |
|
Sleep tracking data and its considerable limitations
Sleep tracking data and its considerable limitations — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published trials in this…
|
+109 | 126 | 61k | 9mo |
|
[2026 update] What a good consultation looks like from the other side
The question in the title: What a good consultation looks like from the other side I will give what I have already checked below so nobody repeats it. Asking about a population rather than about a person. The…
|
+32 | 36 | 13k | 1mo |
|
Journal club: STEP 3 and the intensive behavioural therapy floor
Posting this under the heading it deserves: Journal club: STEP 3 and the intensive behavioural therapy floor Everything below is what sits behind that. Comparing SCALE ( N Engl J Med , 2015) with STEP 4 (…
|
+6 | 10 | 13k | 28d |
|
A 40-week log with the measurement method stated
On the subject in the title: A 40-week log with the measurement method stated Working notes rather than a conclusion. Longitudinal report with the method stated, because a number without a method is not a…
|
+87 | 97 | 18k | 9mo |
|
What happens after your first post: likes, trust levels, and why none of it matters much — what changed since
The question in the title: What happens after your first post: likes, trust levels, and why none of it matters much — what changed since I will give what I have already checked below so nobody repeats it. I…
|
+105 | 118 | 57k | 9mo |
|
New subcategory: rationale and scope
On the subject in the title: New subcategory: rationale and scope Working notes rather than a conclusion. Process question about how this site works. I have read the guidelines and the trust-level page and I…
|
+126 | 138 | 13k | 9mo |
|
Alcohol: what is documented and what is folklore — the long version
Alcohol: what is documented and what is folklore — the long version — setting out what I have, and where I think it stops being reliable. Reporting something rather than asking about it, in case the pattern…
|
+9 | 13 | 7.3k | 6mo |
|
Coverage in the US: a map of the usual obstacles
Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the…
|
+46 | 50 | 7.9k | 5mo |
|
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset
Posting this under the heading it deserves: The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Everything below is what sits behind that. Session topic: STEP 8 ( JAMA ,…
|
+12 | 16 | 11k | 7mo |
|
Revisiting: Gallbladder disease risk with rapid weight loss
Revisiting: Gallbladder disease risk with rapid weight loss Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
|
2 | 2k | 9mo | |
|
Early satiety becoming a problem rather than a benefit
Early satiety becoming a problem rather than a benefit — setting out what I have, and where I think it stops being reliable. A question about technique rather than about dose. I have been doing the same thing…
|
+20 | 24 | 2.5k | 6mo |
|
Is "synergy" the right word for the combination data?
Is "synergy" the right word for the combination data? — that is the question, and I have not found it answered plainly anywhere I have looked. Session topic: SCALE ( N Engl J Med , 2015). Please read it…
|
+5 | 9 | 13k | 25d |